Molecular design of glutathione-derived biochemical probes targeting the GS-X pump

Tetrahedron

Volumn 55, Issue 24, 1999, Pages 7529-7540

  Furuta, Kyoji ^a   Tomokiyo, Keiichiro ^a   Tien Kuo, M ^b   Ishikawa, Toshihisa ^c,d   Suzuki, Masaaki ^a  

^a GIFU UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPHENONE DERIVATIVE; GLUTATHIONE DERIVATIVE;

ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE VESICLE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN TARGETING; REACTION ANALYSIS; TRANSPORT KINETICS;

EID: 0033546318     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(99)00375-0     Document Type: Article

References (51)

1. Recent reviews: (a) Ishikawa, T.; Ali-Osman, F. Glutathione Conjugation and ATP-Dependent Export of Anticancer Drugs. In Drug Transport in Antimicrobial and Anticancer Chemotherapy; Georgopapadakou, N. H. Ed; Marcel Dekker: New York, 1995; pp. 577-612.
2. (b) Ishikawa, T.; Akimaru, K. Structure and Function of GS-X Pump. In Glutathione S-Transferases; Vermeulen, N. P. E.; Mulder, G. J.; Nieuwenhuyse, H.; Peters, W. H. M.; van Bladeren, P. J. Eds.; Taylor and Francis: London, 1996; pp. 199-211.
3. Lautier, D.; Canitrot, Y.; Deeley, R. G.; Cole, S. P. Biochem. Pharmacol. 1996, 52, 967-977.
4. Müller, M.; de Vries, E. G. E.; Jansen, P. L. M. J. Hepatol. 1996, 24 (Suppl. 1), 100-108.
5. (e) Yamazaki, M.; Suzuki, H.; Sugiyama, Y. Pharmaceut. Res. 1996, 13, 497-513.
6. (f) Kavallaris, M. Anti-Cancer Drugs 1997, 8, 17-25.
7. (g) Aigner, A.; Wolf, S.; Gassen, H. G. Angew. Chem. Int. Ed. Engl. 1997, 36, 24-41.
8. (h) Paulusma, C. C.; Oude Elferink, R. P. J. J. Mol. Med. 1997, 75, 420-428.
9. Keppler, D.; König, J. FASEB J. 1997, 11, 509-516.
10. (j) Ishikawa, T.; Li, Z. S.; Lu, Y. P.; Rea, P. A. Bioscience Rep. 1997, 17, 189-207.
11. (a) Akimaru, K.; Kuo, M. T.; Furuta, K.; Suzuki, M.; Noyori, R.; Ishikawa, T. Cytotechnol. 1996, 19, 221-227.
12. (b) Suzuki, M.; Mori, M.; Niwa, T.; Hirata, R.; Furuta, K.; Ishikawa, T.; Noyori, R. J Am. Chem. Soc. 1997, 119, 2376-2385. See also:
13. Evers, R.; Cnubben, N. H.; Wijnholds, J.; van Deemter, L.; van Bladeren, P. J.; Borst, P. FEBS Lett. 1997, 419, 112-116.
14. (a) Ishikawa, T.; Akimaru, K.; Kuo, M. T.; Priebe, W.; Suzuki, M. J. Natl. Cancer Inst. 1995, 87, 1639-1640. See also:
15. (b) Broxterman, H. J.; Heijn, M.; Lankelma, J. J. Natl. Cancer Inst. 1996, 88, 466-467.
16. Ishikawa, T.; Akimaru, K.; Kuo, M. T.; Priebe, W.; Suzuki, M. J. Natl. Cancer Inst. 1996, 88, 467-468.
17. Priebe, W.; Krawczyk, M.; Kuo, M. T.; Yamane, Y.; Savaraj, N.; Ishikawa, T. Biochem. Biophys. Res. Commun. 1998, 247, 859-863.
18. (a) Ishikawa, T. J. Biol. Chem. 1989, 264, 17343-17348.
19. (b) Ishikawa, T. FEBS Lett. 1989, 246, 177-180.
20. Ishikawa, T.; Kobayashi, K.; Sogame, Y.; Hayashi, K. FEBS Lett. 1989, 259, 95-98.
21. For recent reports on the photoaffinity labeling of related transporter proteins, see: (a) Leier, I.; Jedlitschky, G.; Buchholz, U.; Keppler, D. Eur. J. Biochem. 1994, 220, 599-606.
22. (b) Jedlitschky, G.; Leier, I.; Buchholz, U.; Center, M.; Keppler, D. Cancer Res. 1994, 54, 4833-4836.
23. Pikula, S.; Hayden, J. B.; Awasthi, S.; Awasthi, Y. C.; Zimniak, P. J. Biol. Chem. 1994, 269, 27566-27573.
24. Leier, I.; Jedlitschky, G.; Buchholz, U.; Cole, S. P. C.; Deeley, R. G.; Keppler, D. J. Biol. Chem. 1994, 269, 27807-27810.
25. (e) Pulaski, L.; Jedlitschky, G.; Leier, I.; Buchholz, U.; Keppler, D. Eur. J. Biochem. 1996, 241, 644-648.
26. (f) Leier, I.; Jedlitschky, G.; Büchler, M.; Buchholz, U.; Brom, M.; Keppler, D. Eur. J. Biochem. 1996, 242, 201-205.
27. (g) Loe, D. W.; Almquist, K. C.; Deeley, R. G.; Cole, S. P. C. J. Biol. Chem. 1996, 271, 9675-9682.
28. (a) Galardy, R. E.; Craig, L. C.; Jamieson, J. D.; Printz, M. P. J. Biol. Chem. 1974, 249, 3510-3518.
29. (b) Dormán, G.; Prestwich, G. D. Biochemistry. 1994, 33, 5662-5673.
30. Fleming, S. A. Tetrahedron 1995, 51, 12479-12520.
31. (a) Ishikawa, T. Trends Biochem. Sci. 1990, 15, 219-220. See also:
32. (b) Cole, S. P.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M.; Deeley, R. G. Science 1992, 258, 1650-1654.
33. Paul, S.; Belinsky, M. G.; Shen, H.; Kruh, G. D. Biochemistry 1996, 55, 13647-13655.
34. (a) Levy, E. L.; Anderson, M. E.; Meister, A. Proc. Natl. Acad. Sci. USA 1993, 90, 9171-9175.
35. (b) Minhas, H. S.; Thornalley, P. J. Biochem. Pharmacol. 1995, 49, 1475-1482.
36. (a) Ishikawa, T.; Wright, C. D.; Ishizuka, H. J. Biol. Chem. 1990, 269, 29085-29093.
37. (b) Ishikawa, T.; Wright, C. D.; Ishizuka, H. J. Biol. Chem. 1994, 269, 29085-29093.
38. Ishikawa, T.; Bao, J. J.; Yamane, Y.; Akimaru, K.; Frindrich, K.; Wright, C. D.; Kuo, M. T. J. Biol. Chem. 1996, 271, 14981-14988.
39. Pyrene has been used as a fluorescent probe to monitor the physiological properties of lipid bilayers, see: (a) Shinitzky, M.; Barenholz, Y. J. Biol. Chem. 1974, 249, 2652-2657.
40. (b) Overath, P.; Traüble, H. Biochemistry 1973, 12, 2625-2634.
41. Galla, H.-J.; Sackmann, E. Biochem. Biophys. Acta 1974, 339, 103-115.
42. (a) Ishikawa, T.; Akimaru, K.; Nakanishi, M.; Tomokiyo, K.; Furuta, K.; Suzuki, M.; Noyori, R. Biochem. J. 1998, 336, 569-576.
43. (b) Ishikawa, T.; Kuo, M. T.; Furuta, K.; Suzuki, M. A New Aspect on Glutathione-associated Biological Function of MRP/GS-X Pump and Its Gene Expression. In Multiple Drug Resistance in Cancer 2; Clynes, M. Ed; Kluwer Academic Publishers: Dordrecht, 1999; pp. 81-93.
44. For sensitization of MRP-associated multi-drug resistant cells to anticancer drugs, see: (a) Gekeler, V.; Boer, R.; Ise, W.; Sanders, K. H.; Schächtele, C.; Beck, J. Biochem. Biophys. Res. Commun. 1995, 206, 119-126.
45. (b) Gekeler, V.; Ise, W.; Sanders, K. H.; Ulrich, W-R.; Beck, J. Biochem. Biophys. Res. Commun. 1995, 208, 345-352.
46. Wijnholds, J.; Evers, R.; van Leusden, M. R.; Mol, C. A. A. M.; Zaman, G. J. R.; Mayer, U.; Beijnen, J. H.; van der Valk, M.; Krimpenfort, P.; Borst, P. Nature Medicine 1997, 3, 1275-1279.
47. Chen, Z-S.; Mutoh, M.; Sumizawa, T.; Furukawa, T.; Haraguchi, M.; Tani, A.; Akiyama, S. Biochem. Biophys. Res. Commun. 1997, 236, 586-590.
48. (e) Gollapudi, S.; Kim, C. H.; Tran, B-N.; Sangha, S.; Gupta, S. Cancer Chemother. Pharmacol. 1997, 40, 150-158.
49. (f) Draper, M. P.; Martell, R. L.; Levy, S. B. British J. Cancer 1997, 75, 810-815.
50. Akimaru, K.; Nakanishi, M.; Suzuki, M.; Furuta, K.; Noyori, R.; Ishikawa, T. Adv. Exp. Med. Biol. 1997, 407, 387-391.
51. The cell cycle was concomitantly arrested at the G1 phase without causing cell death. No inhibitory effect was observed by the use of 4b alone for the cells.